Leerink raises Encompass Health stock price target on growth outlook
Leerink has increased its price target for Encompass Health Corp (NYSE:EHC) shares to $152 from $138, maintaining an Outperform rating. This adjustment reflects the company's strong growth prospects driven by historically high bed additions and de novo facilities, leading to record-high return on invested capital and over 10% year-over-year revenue growth. Leerink also anticipates diminishing risks and a positive revision path for the stock, despite recent controversies.
Encompass Health to expand Idaho presence with new 50-bed facility
Encompass Health plans to expand its presence in Idaho by constructing a new 50-bed inpatient rehabilitation hospital in Post Falls. This facility will mark Encompass Health's second inpatient rehabilitation hospital in Idaho, complementing its existing location in Boise. The Post Falls hospital aims to provide comprehensive rehabilitative services to patients recovering from various serious illnesses and injuries.
EHC6397524 Bond Price and Chart — FINRA:EHC6397524
This article provides details on the Encompass Health Corporation's EHC6397524 bond, which has a 5.875% coupon and matures on June 1, 2034. Key terms such as outstanding amount, face value, minimum denomination, and coupon frequency are outlined. The article also includes information about Encompass Health Corp., the bond's issuer, describing it as a provider of post-acute healthcare services.
Encompass Health EVP & CFO Coltharp sells $2.96m in stock
Douglas E. Coltharp, EVP and CFO of Encompass Health Corp (EHC), sold 27,694 shares of company stock for approximately $2.96 million on May 15, 2026. This sale followed his acquisition of the same number of shares through stock option exercises. Despite the sale, Coltharp maintains significant direct and indirect holdings in the company, which recently announced a $500 million senior notes offering, plans for a new inpatient rehabilitation hospital, and a quarterly dividend.
AlphaCore Capital LLC Invests $4.88 Million in Encompass Health Corporation $EHC
AlphaCore Capital LLC initiated a new position in Encompass Health Corporation (NYSE:EHC), purchasing 45,991 shares valued at approximately $4.88 million in the fourth quarter. Analysts maintain a "Buy" consensus for EHC, forecasting solid earnings for the current fiscal year with an average target price of $144.17. The company recently exceeded quarterly expectations, reporting diluted EPS of $1.60 and revenue of $1.59 billion, and declared a quarterly dividend of $0.19 per share.
Encompass Health Announces New Senior Notes Offering
Encompass Health announced a private offering of $500 million in 5.875% senior unsecured notes due 2034. The company plans to use the proceeds to redeem outstanding 2028 notes and repay a portion of its revolving credit facility, aiming to extend its debt maturity profile and re-balance its capital structure. The move is expected to enhance financial flexibility and provide clarity for bondholders.
Encompass Health Corporation (NYSE:EHC) Receives Average Recommendation of "Buy" from Analysts
Encompass Health Corporation (NYSE:EHC) has received an average "Buy" recommendation from analysts, with a 12-month target price of approximately $144.17. The company recently reported strong quarterly results, beating EPS and revenue expectations, and raised its FY 2026 EPS guidance. Despite some insider selling, institutional investors have increased their holdings, indicating mixed but generally positive sentiment.
Encompass Health (NYSE: EHC) prices $500M 5.875% senior notes due 2034
Encompass Health (NYSE: EHC) has priced a private offering of $500 million in 5.875% senior notes due 2034. The company plans to use the net proceeds, along with cash on hand, to redeem $400 million of its outstanding 4.500% Senior Notes due 2028 and repay $100 million under its revolving credit facility. The offering is expected to close around May 29, 2026, and the notes will be guaranteed by certain subsidiaries.
Encompass Health To Issue $500 Million 5.875% Senior Notes Due 2034
Encompass Health (EHC) plans to issue $500 million of 5.875% senior notes due 2034 through a private offering, with Wells Fargo Securities acting as the representative for initial purchasers. The company intends to use the proceeds, combined with cash, to redeem $400 million of existing notes due 2028, repay $100 million on its revolving credit facility, and cover associated fees. The offering is anticipated to close around May 29, 2026.
[144] Encompass Health Corp SEC Filing
This article reports on an SEC Form 144 filing by Encompass Health Corp (EHC) on May 15, 2026, detailing a proposed sale of 27,694 shares of common stock with an aggregate market value of $2,958,629.19. The shares are to be sold by an unnamed individual, acquired through a stock option exercise, through UBS Financial Services Inc. The filing indicates a "Neutral" impact and sentiment.
Encompass Health announces private offering of senior notes
Encompass Health Corp. announced a private offering of $500 million in senior notes maturing in 2034. The net proceeds will be used to redeem $400 million of existing 4.500% Senior Notes due 2028 and repay $100 million of its revolving credit facility. The offering is subject to market and other conditions.
Encompass Health to pay off $400M of 2028 debt in June
Encompass Health (NYSE:EHC) announced its plan to redeem $400 million of its 4.500% senior notes due 2028. The redemption will occur at 100% of par plus accrued interest, with payment expected on June 15, 2026. This action is anticipated to result in a $3.2 million loss on early extinguishment of debt in Q2 2026, leaving $400 million of these notes outstanding.
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health Corp. has announced a partial redemption of $400 million of its 4.500% senior notes due 2028. The redemption price will be 100.0% of par plus accrued interest, with payment expected on June 15, 2026. This action is anticipated to result in an approximate $3.2 million loss on early extinguishment of debt in the second quarter of 2026 for the company.
Encompass Health prices $500M debt to redeem 2028 notes, repay loan
Encompass Health (NYSE: EHC) has priced a private offering of $500 million in 5.875% senior notes due 2034, with an expected closing date of May 29, 2026. The proceeds will be used to redeem $400 million of its 4.500% senior notes due 2028 and repay $100 million outstanding on its senior secured revolving credit facility, along with associated fees. This move aims to refinance existing debt and extend the company's debt maturity profile.
Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Encompass Health Corp. announced the pricing of a private offering of $500 million of 5.875% senior notes due 2034. The company plans to use the net proceeds to redeem $400 million of its outstanding 4.500% Senior Notes due 2028 and repay $100 million under its revolving credit facility. The offering is expected to close on May 29, 2026, subject to customary conditions.
Encompass Health (EHC) Launches $500 Million Senior Notes Offeri
Encompass Health (EHC) has announced a $500 million private offering of senior notes due in 2034, intending to refinance existing debt and optimize its capital structure. According to GuruFocus, the stock is currently undervalued with a GF Value™ of $110.44 against a current price of $106.96, and boasts a strong GF Score™ of 89/100, indicating robust profitability and growth despite some insider selling. This move aims to extend debt maturity and enhance financial flexibility in the healthcare market.
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health Corp. announced a partial redemption of $400 million of its 4.500% senior notes due 2028. The redemption price will be 100.0% of par plus accrued interest, with a redemption date of June 13, 2026, and payment on June 15, 2026. The Company expects to record an approximate $3.2 million loss on early extinguishment of debt in the second quarter of 2026 as a result.
Encompass Health announces private offering of senior notes
Encompass Health Corp. has announced a private offering of $500 million in senior notes due 2034. The company plans to use the net proceeds, along with cash on hand, to redeem $400 million of its 4.500% Senior Notes due 2028 and repay $100 million from its revolving credit facility. The offering targets qualified institutional buyers and certain non-U.S. persons, with the notes not registered under the Securities Act.
[Form 4] Encompass Health Corp Insider Trading Activity
Patrick William Tuer, EVP and Chief Operating Officer of Encompass Health Corp (EHC), sold 682 shares of company stock at $104.56 per share on May 11, 2026. After this open-market transaction, Tuer directly holds 24,755 shares. The sale, valued at $71,310, was reported in a Form 4 filing, which provides transparency on insider trading activity.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
Encompass Health Corp. (NYSE: EHC) has announced plans to construct a new 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, expected to open in 2028. This facility will provide specialized care for patients recovering from various debilitating conditions, including stroke, brain and spinal cord injuries, and amputations. It will be the company's second location in Idaho and aims to address the growing need for inpatient rehabilitation services in the rapidly expanding Kootenai County area.
Encompass Health (EHC) director receives 1,634-share annual RSU grant
Encompass Health Corp director Cain A. Hayes was granted 1,634 shares of Encompass Health Common Stock as restricted stock units under the company's 2025 Omnibus Performance Incentive Plan. This annual compensation-related award increased Hayes' direct holdings to 2,092 shares, with the transaction price reported as $0.0000 per share.
EHC SEC Filings - Encompass Health Corp 10-K, 10-Q, 8-K Forms
This article provides a comprehensive list of recent SEC filings for Encompass Health Corp (EHC), including 10-K, 10-Q, and 8-K forms, as well as insider trading disclosures. Each filing is accompanied by an AI-generated summary, impact score, and sentiment analysis. Key filings discussed include insider stock sales, share transfers to family trusts, Q2 2025 financial results showing significant revenue growth and adjusted EBITDA, and an Investor Reference Book outlining the company's expansion strategy and financial metrics.
Encompass Health (EHC) director receives 1,634-share restricted stock grant
Encompass Health Corp. director Christopher R. Reidy received a grant of 1,634 shares of Encompass Health Common Stock as part of his annual restricted stock units under the company's 2025 Omnibus Performance Incentive Plan. These shares were awarded at a price of $0.00 per share, and following this transaction, Reidy directly holds 17,437 shares. This grant represents a compensation-related award rather than an open-market purchase or sale.
Encompass Health (EHC) director Joan Herman granted 1,634 RSUs as annual award
Encompass Health (EHC) director Joan E. Herman received an annual grant of 1,634 restricted stock units (RSUs) as part of the company's 2025 Omnibus Performance Incentive Plan. This compensation award, which had a price of $0.00 per share, resulted in her directly holding 49,558 shares of Encompass Health common stock. The transaction is classified as a routine equity compensation grant rather than an open-market purchase or sale.
Encompass Health to participate in BofA Securities 2026 Health Care Conference
Encompass Health Corporation (EHC) is scheduled to participate in the BofA Securities 2026 Health Care Conference. This information was released via a Quantisnow press release. Quantisnow is a platform that provides real-time market data and news to retail investors, including press releases, SEC filings, and analyst ratings.
Encompass Health plans 50-bed hospital in Post Falls, Idaho
Encompass Health Corp. (NYSE:EHC) announced plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, expected to open in 2028. This will be the company's second facility in Idaho, expanding its network of 175 hospitals across various states. The announcement follows a strong financial quarter for Encompass Health, with earnings and revenue surpassing analyst expectations, and a declared quarterly cash dividend.
[144] Encompass Health Corp SEC Filing
This article details an SEC Form 144 filing by Encompass Health Corp (EHC) for a proposed sale of securities. The filing indicates a sale of 682 shares of common stock with an aggregate market value of $71,312.3, acquired through RSA Vesting on February 28, 2026. The notice, dated May 11, 2026, also includes information about the company and its recent financial activities and SEC filings.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
Encompass Health Corp. (NYSE: EHC) has announced plans to construct a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho. This facility, expected to open in 2028, will provide specialized care for patients recovering from various debilitating illnesses and injuries, including stroke and spinal cord injuries. It will be the company's second hospital in Idaho, addressing the growing need for inpatient rehabilitation services in Kootenai County.
Encompass Health (NYSE: EHC) 2026 Annual Meeting sees all directors, pay and auditor approved
Encompass Health Corporation announced the results of its 2026 Annual Meeting, where shareholders approved all key proposals. This included the election of ten directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and the advisory approval of executive compensation. The meeting saw strong shareholder participation, with 92.5% of combined voting power represented by proxy.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
Encompass Health (NYSE: EHC) has announced plans to construct a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, expected to open in 2028. This facility will provide specialized care for patients recovering from debilitating illnesses and injuries, offering physical, occupational, and speech therapies. This will be Encompass Health's second location in Idaho, addressing an underserved need in the rapidly growing Kootenai County.
Encompass Health (EHC) director receives 1,634-share annual equity grant
Encompass Health Corp director Greg D. Carmichael received an annual equity grant of 1,634 shares of Encompass Health Common Stock on May 7, 2026. This grant was issued as restricted stock units under the company's 2025 Omnibus Performance Incentive Plan. Following this transaction, Carmichael directly holds 20,320 shares of Encompass Health Common Stock.
Encompass Health (EHC) director awarded 1,634-share stock grant
Encompass Health Corp director Kevin J. O'Connor received a grant of 1,634 shares of Encompass Health Common Stock as part of his annual restricted stock unit grant under the company's 2025 Omnibus Performance Incentive Plan. This equity award, at no cash cost, increases O'Connor's direct holdings to 11,563 shares of Encompass Health Common Stock. The transaction was reported in a Form 4 filing, indicating a routine compensation-related increase in his ownership stake.
Director at Encompass Health (NYSE: EHC) awarded 1,634 RSUs
Edward M. Christie III, a director at Encompass Health (NYSE: EHC), was awarded 1,634 Restricted Stock Units (RSUs) on May 7, 2026, as part of an annual equity award under the company's 2025 Omnibus Performance Incentive Plan. These RSUs were granted at $0.00 per share, increasing his direct holdings to 9,086 shares. The filing indicates this is routine compensation and not a discretionary trading decision.
Encompass Health declares $0.19 quarterly dividend
Encompass Health Corp. (NYSE:EHC) has announced a quarterly cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. This follows the company's strong first-quarter 2026 earnings, where it surpassed analyst expectations with an EPS of $1.60 and revenue of $1.59 billion. Truist Securities maintained a Buy rating and a $140.00 price target, highlighting the company's adjusted EBITDA being ahead of expectations and increased guidance.
Encompass Health declares dividend on common stock
Encompass Health Corp. (NYSE: EHC) has announced a quarterly cash dividend of $0.19 per share on its common stock. The dividend is payable on July 15, 2026, to shareholders of record as of July 1, 2026. Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with 175 facilities across 39 states and Puerto Rico.
Encompass Health declares dividend on common stock
Encompass Health Corp. has declared a quarterly cash dividend of $0.19 per share on its common stock. The dividend is payable on July 15, 2026, to shareholders of record as of July 1, 2026. Encompass Health is a leading owner and operator of inpatient rehabilitation hospitals in the United States.
Encompass Health Q1 EPS Tops, Revenues Climb on Solid Discharges
Encompass Health (EHC) reported strong Q1 results, with adjusted EPS beating consensus by 6% and revenues increasing 9.1% year-over-year, marginally surpassing estimates. The growth was primarily driven by solid discharge volumes and higher net patient revenue per discharge, despite increased operating expenses. The company also updated its 2026 outlook, raising revenue and adjusted EBITDA expectations while maintaining its long-term growth targets.
Encompass Health Rehabilitation Hospital of Concordville now open in Pennsylvania – Company Announcement
Encompass Health announced the opening of its 10th Pennsylvania location, the 50-bed Encompass Health Rehabilitation Hospital of Concordville in Delaware County. The hospital will provide intensive rehabilitation services for patients recovering from various conditions, offering a range of amenities and advanced therapy technologies. Encompass Health plans to open another hospital in Lower Providence later this year.
A new 50-bed rehab hospital starts taking patients in Delaware County
Encompass Health has officially opened its 50-bed Rehabilitation Hospital of Concordville in Delaware County, Pennsylvania, now accepting patients for inpatient rehabilitation. This new 66,000-square-foot facility offers intensive therapy for various conditions, marking Encompass Health's 10th location in Pennsylvania. The opening follows the company's strong Q1 2026 financial performance, with plans for further expansion in the state later this year.
Encompass Health Rehabilitation Hospital of Concordville now open in Pennsylvania
Encompass Health has opened its 10th inpatient rehabilitation hospital in Pennsylvania, the Encompass Health Rehabilitation Hospital of Concordville. This 50-bed facility in Delaware County will provide intensive physical, occupational, and speech therapy for patients recovering from various serious conditions. The hospital is equipped with advanced rehabilitation technologies and specialized amenities to help patients regain functional ability and improve their quality of life.
Truist reiterates Encompass Health stock rating on solid results
Truist Securities has reiterated a Buy rating and a $140 price target for Encompass Health Corp (NYSE:EHC) after the company reported strong first-quarter results, with adjusted EBITDA exceeding expectations and a subsequent guidance increase. The firm highlighted robust core demand trends and the company's financial flexibility, which supports its development pipeline and shareholder initiatives. Encompass Health's Q1 2026 earnings surpassed analyst expectations, reporting an EPS of $1.60 and revenue of $1.59 billion, indicating strong financial performance.
Encompass Health Corporation (NYSE:EHC) Q1 2026 Earnings Call Transcript
Encompass Health Corporation reported a strong start to 2026 with a 9% increase in Q1 revenue and an 11.2% rise in adjusted EBITDA, leading to an upward revision of its 2026 guidance. The company highlighted outstanding patient outcomes, improved clinical staff turnover rates, and continued investment in capacity expansion through new hospitals and bed additions. Discussions also covered regulatory changes, the impact of unit closures on discharge growth, management of Medicare Advantage patients, and the strategic development of smaller format hospitals.
Vanguard Group Inc. Lowers Stake in Encompass Health Corporation $EHC
Vanguard Group Inc. reduced its stake in Encompass Health Corporation by 1.1% in Q4, selling over 110,000 shares, though still holding 10.07% of the company. This comes despite Encompass Health reporting strong Q1 earnings with EPS of $1.60 and revenue of $1.59B, beating analyst expectations, and raising FY 2026 guidance. Separately, insider selling includes CEO Mark J. Tarr selling 150,000 shares and the treasurer selling 11,937 shares, leading to insiders holding only 1.80% ownership.
Encompass Health Q1 2026 slides: revenue up 9%, guidance raised By Investing.com
Encompass Health (NYSE:EHC) reported strong Q1 2026 results, with revenue up 9.0%, adjusted EBITDA growing 11.2%, and adjusted EPS increasing 16.8%. The company raised its full-year 2026 guidance across all key metrics and continues to expand its national footprint with new facilities and bed additions. Encompass Health's strategic growth initiatives and disciplined capital allocation aim to capitalize on favorable demographics and an under-penetrated rehabilitation market.
Encompass Health (NYSE:EHC) Upgraded at Wall Street Zen
Encompass Health (NYSE:EHC) received an upgrade from "hold" to "buy" by Wall Street Zen, while Barclays raised its price target to $153. The company reported strong Q1 results, with EPS of $1.60 and revenue of $1.59 billion, exceeding analyst expectations and leading to an increase in its FY 2026 EPS guidance. Despite recent insider selling, institutional investors show significant ownership in Encompass Health.
Encompass Health Lifts 2026 Outlook After Strong Q1
Encompass Health (EHC) reported strong Q1 2026 results with significant increases in net operating revenue, diluted EPS, and Adjusted EBITDA, leading them to lift their full-year 2026 guidance. The company continues to expand its capacity by opening new hospitals and adding beds to existing facilities, validating its operating strategy. Analysts have a Buy rating on EHC stock with a $145.00 price target, and TipRanks’ AI Analyst rates EHC as Outperform due to solid profitability and an improved balance sheet.
Encompass Health jumps 7.5% as Q1 results and raised 2026 outlook boost sentiment
Encompass Health (EHC) saw its stock rise by 7.5% after reporting strong first-quarter 2026 earnings and raising its full-year 2026 outlook. The company's net income reached $194.5 million, and it now expects full-year earnings between $5.89 and $6.11 per share with revenue of $6.38 billion to $6.47 billion. This positive investor reaction was also influenced by ongoing growth trends and reinforced confidence in their 2026 plan.
Encompass Health Corporation $EHC Shares Sold by Jennison Associates LLC
Jennison Associates LLC significantly reduced its stake in Encompass Health Corporation ($EHC) by 37.3% in Q4, selling 333,732 shares. This comes alongside recent insider selling by the CEO and Treasurer. Despite these sales, Encompass Health beat quarterly earnings estimates and received a consensus "Buy" rating from analysts with an average price target of $146.33.
Earnings Flash (EHC) Encompass Health Corporation Reports Q1 Revenue $1.59B, vs. FactSet Est of $1.57B
Encompass Health Corporation (EHC) announced its Q1 revenue reached $1.59 billion, surpassing FactSet's estimated $1.57 billion. The company also posted adjusted EPS of $1.60 per share, exceeding analyst expectations of $1.49. This financial update, released on April 30, 2026, highlights a strong start to the year for the healthcare facilities and services provider.
Encompass Health (NYSE: EHC) boosts 2026 guidance on strong Q1 revenue and EPS growth
Encompass Health (NYSE: EHC) reported strong Q1 2026 financial results, with net operating revenue growing 9.0% to $1,586.6 million and adjusted EPS rising 16.8% to $1.60. The company also raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted earnings per share, reflecting confidence in its growth strategy and operational performance. This positive outlook is supported by continued capacity expansion and manageable leverage.
